These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8562404)

  • 21. Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking.
    Ebberink EH; Bouwens EA; Bloem E; Boon-Spijker M; van den Biggelaar M; Voorberg J; Meijer AB; Mertens K
    Haematologica; 2017 Apr; 102(4):686-694. PubMed ID: 28057741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of smoking as a risk factor for activated protein C resistance during pregnancy.
    Kafkas S; Kalkan U; Bolaman Z; Sanci M; Yüksel H; Odabaşi AR
    Gynecol Obstet Invest; 2007; 64(2):89-94. PubMed ID: 17314487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A chromogenic assay for activated protein C resistance.
    Váradi K; Moritz B; Lang H; Bauer K; Preston E; Peake I; Rivard GE; Keil B; Schwarz HP
    Br J Haematol; 1995 Aug; 90(4):884-91. PubMed ID: 7669667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives.
    Hellgren M; Svensson PJ; Dahlbäck B
    Am J Obstet Gynecol; 1995 Jul; 173(1):210-3. PubMed ID: 7631684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated protein C resistance in normal and pre-eclamptic pregnancies.
    Paternoster DM; Stella A; Simioni P; Girolami A; Snijders D
    Gynecol Obstet Invest; 2002; 54(3):145-9. PubMed ID: 12571435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women.
    Tanaka KA; Bharadwaj S; Hasan S; Judd M; Abuelkasem E; Henderson RA; Chow JH; Williams B; Mazzeffi MA; Crimmins SD; Malinow AM
    Br J Anaesth; 2019 Jun; 122(6):751-759. PubMed ID: 30916034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired APC resistance in neurosurgical patients may not be a risk factor for postoperative deep vein thrombosis.
    Meinardi JR; Henkens CM; de Kam PJ; van der Meer J
    Clin Appl Thromb Hemost; 1999 Apr; 5(2):105-9. PubMed ID: 10725989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated protein C resistance shows an association with pregnancy-induced hypertension.
    Horstkamp BS; Kiess H; Krämer J; Riess H; Henrich W; Dudenhausen JW
    Hum Reprod; 1999 Dec; 14(12):3112-5. PubMed ID: 10601105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Structural-functional features of factor VIII (FVIII) and its role in the cascade system of blood coagulation].
    Gutsalo AE
    Ukr Biokhim Zh (1978); 1995; 67(4):12-23. PubMed ID: 8553466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombin-activated and factor Xa-activated human factor VIII: differences in cofactor activity and decay rate.
    Neuenschwander PF; Jesty J
    Arch Biochem Biophys; 1992 Aug; 296(2):426-34. PubMed ID: 1632634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
    Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
    J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orthostatic hypercoagulability: a novel physiological mechanism to activate the coagulation system.
    Masoud M; Sarig G; Brenner B; Jacob G
    Hypertension; 2008 Jun; 51(6):1545-51. PubMed ID: 18413485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of oral contraceptives on factor VIII clotting activity and factor VIII related antigen in normal women.
    Stableforth P; Montgomery DC; Wilson E; Churchill WG; Dormandy KM; Hardisty RM
    J Clin Pathol; 1975 Jun; 28(6):498-501. PubMed ID: 1141452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss--a possible evolutionary selection mechanism.
    Lindqvist PG; Svensson PJ; Dahlbäck B; Marsál K
    Thromb Haemost; 1998 Jan; 79(1):69-73. PubMed ID: 9459326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated protein C resistance in Turkish women with severe preeclampsia.
    Cetin M; Güçer S; Serin IS; Eser B; Tayyar M; Unal A
    Gynecol Obstet Invest; 2001; 52(3):168-72. PubMed ID: 11598358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor V and protein S as cofactors to activated protein C.
    Dahlbäck B
    Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor IXa and von Willebrand factor modify the inactivation of factor VIII by activated protein C.
    Rick ME; Esmon NL; Krizek DM
    J Lab Clin Med; 1990 Apr; 115(4):415-21. PubMed ID: 2109028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of the APTT- and ETP-based APC sensitivity tests.
    de Visser MC; van Hylckama Vlieg A; Tans G; Rosing J; Dahm AE; Sandset PM; Rosendaal FR; Bertina RM
    J Thromb Haemost; 2005 Jul; 3(7):1488-94. PubMed ID: 15978106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired APC resistance related to oral contraceptives and pregnancy and its possible implications for clinical practice.
    Meinardi JR; Henkens CM; Heringa MP; van der Meer J
    Blood Coagul Fibrinolysis; 1997 Mar; 8(2):152-4. PubMed ID: 9518048
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of factor VIII on activated protein C resistance ratio in inflammatory diseases.
    Mathonnet F; de Mazancourt P; Denninger MH; Morot M; Benattar N; Giudicelli Y
    Br J Haematol; 1996 Nov; 95(2):423-5. PubMed ID: 8904903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.